EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Helyx Industries SpA EBITDA Margin % Related Terms
Helyx Industries SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Helyx Industries SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:HLX vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Helyx Industries SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helyx Industries SpA EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Helyx Industries SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Helyx Industries SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helyx Industries SpA (MIL:HLX) has a EBITDA Margin % of -32.89% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Helyx Industries SpA and its competitors. According to the industry distribution chart, Helyx Industries SpA ranks #470 out of 944 companies in the Biotechnology industry, placing it in the top 49.8%.
Is Helyx Industries SpA's EBITDA Margin % too high?
Helyx Industries SpA's current EBITDA Margin % is -32.89%. Based on the distribution chart, Helyx Industries SpA ranks #470 out of 944 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Helyx Industries SpA has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Helyx Industries SpA's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helyx Industries SpA ranks #470 out of 944 companies for EBITDA Margin %. This puts Helyx Industries SpA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Helyx Industries SpA and its competitors. Helyx Industries SpA's current EBITDA Margin % is -32.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helyx Industries SpA stock overvalued right now?
Based on GuruFocus' analysis, Helyx Industries SpA (MIL:HLX) is currently considered Possible Value Trap. The stock's GF Value™ is €3.44, compared to a current price of €0.76 — trading 77.8% below its estimated fair value. The current EBITDA Margin % is -32.89%. Helyx Industries SpA's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Helyx Industries SpA (MIL:HLX), the current EBITDA Margin % is -32.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Helyx Industries SpA (MIL:HLX) Overvalued in 2026?
Based on GuruFocus' analysis, Helyx Industries SpA stock appears to be undervalued.
The current stock price of €0.76 is trading 77.8% below its estimated GF Value™ of €3.44.
GuruFocus considers Helyx Industries SpA to be Possible Value Trap.
Key valuation signals for MIL:HLX:
EBITDA Margin %: -32.89%
GF Value™: €3.44 vs. price of €0.76 (77.8% below fair value)
No single metric tells the full story. See the MIL:HLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Helyx Industries SpA is a healthcare biotech company focusing on genetics. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions.
59GF Score
Get the complete analysis for MIL:HLX
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HLX has been successfully added to your 
